[{"indications": "Indications\u00a0see under Dose", "name": "ITRACONAZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.2 Antifungal drugs", "5.2.1 Triazole antifungals", "ITRACONAZOLE"], "cautions": "Cautions\u00a0absorption\r\nreduced in HIV-infection and neutropenia (monitor plasma-itraconazole concentration and increase dose if necessary); susceptibility to congestive heart failure (see also\r\nHeart Failure, below); interactions: Appendix 1 (antifungals,\r\ntriazole)Hepatotoxicity\u00a0Potentially life-threatening hepatotoxicity\r\nreported very rarely\u2014discontinue if signs of hepatitis\r\ndevelop. Avoid or use with caution if history\r\nof hepatotoxicity with other drugs or in active liver disease. Monitor liver function\r\nif treatment continues for longer than one month, if receiving other\r\nhepatotoxic drugs, if history of hepatotoxicity with other drugs,\r\nor in hepatic impairmentCounselling\u00a0Patients should be told\r\nhow to recognise signs of liver disorder and advised to seek prompt\r\nmedical attention if symptoms such as anorexia, nausea, vomiting,\r\nfatigue, abdominal pain or dark urine developHeart failureFollowing reports of heart failure, caution is advised when\r\nprescribing itraconazole to patients at high risk of\r\nheart failure. Those at risk include:patients receiving high doses and longer treatment courses;older patients and those with cardiac disease;patients receiving treatment with negative\r\ninotropic drugs, e.g. calcium channel blockers.Itraconazole should be avoided in patients with ventricular\r\ndysfunction or a history of heart failure unless the infection is\r\nserious.", "side-effects": "Side-effects\u00a0nausea, abdominal pain, rash; less commonly vomiting, dyspepsia, taste disturbances, flatulence, diarrhoea,\r\nconstipation, oedema, headache, dizziness, paraesthesia (discontinue\r\ntreatment if neuropathy), menstrual disorder, and alopecia; rarely pancreatitis, dyspnoea, hypoaesthesia, urinary frequency,\r\nleucopenia, visual disturbances, and tinnitus; also reported, heart\r\nfailure (see Cautions above), hypertriglyceridaemia, hepatitis (see\r\nHepatotoxicity above), erectile dysfunction, thrombocytopenia,\r\nhypokalaemia, myalgia, arthralgia, photosensitivity, toxic epidermal\r\nnecrolysis, and Stevens\u2013Johnson syndrome; with intravenous\r\ninjection hypertension and hyperglycaemia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202624.htm", "doses": ["By mouth, oropharyngeal candidiasis,\r\nsee under Sporanox\u00ae oral liquid below", "Vulvovaginal candidiasis, (see also Recurrent Vulvovaginal Candidiasis, section 7.2.2) 200\u00a0mg\r\ntwice daily for 1 day", "Pityriasis versicolor, 200\u00a0mg once daily for 7 days", "Tinea corporis and tinea cruris, either 100\u00a0mg\r\nonce daily for 15 days or 200\u00a0mg once daily for 7\r\ndays", "Tinea pedis and tinea manuum, either 100\u00a0mg\r\nonce daily for 30 days or 200\u00a0mg twice daily for\r\n7 days", "Onychomycosis, either 200\u00a0mg once daily for\r\n3 months or course (\u2018pulse\u2019) of 200\u00a0mg twice daily\r\nfor 7 days, subsequent courses repeated after 21-day interval; fingernails\r\n2 courses, toenails 3 courses", "Aspergillosis, 200\u00a0mg twice daily", "Histoplasmosis, 200\u00a0mg 3 times daily for 3 days, then 200\u00a0mg\r\nonce or twice daily", "Systemic candidiasis and cryptococcosis including cryptococcal\r\nmeningitis where other antifungal drugs inappropriate or ineffective,\r\n200\u00a0mg once daily (candidiasis 100\u2013200\u00a0mg once daily) increased in\r\ninvasive or disseminated disease and in cryptococcal meningitis to\r\n200\u00a0mg twice daily", "Maintenance in HIV-infected patients to prevent relapse of underlying\r\nfungal infection and prophylaxis in neutropenia when standard therapy\r\ninappropriate, 200\u00a0mg once daily, increased to 200\u00a0mg twice daily\r\nif low plasma-itraconazole concentration (see Cautions)", "Prophylaxis in patients with haematological malignancy or undergoing\r\nbone-marrow transplant, see under Sporanox\u00ae oral\r\nliquid below", "By intravenous infusion, systemic\r\naspergillosis, candidiasis and cryptococcosis including cryptococcal\r\nmeningitis where other antifungal drugs inappropriate or ineffective,\r\nhistoplasmosis, 200\u00a0mg every 12 hours for 2 days, then 200\u00a0mg once\r\ndaily for max. 12 days", "child under 18 years\r\nsee BNF for Children", "Itraconazole doses in BNF may differ from\r\nthose in product literature"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only in life-threatening\r\nsituations (toxicity at high doses in animal studies);\r\nensure effective contraception during treatment and until the next\r\nmenstrual period following end of treatment"}]